Company / Cash per Share
West Pharmaceutical Services Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$10.94
FY2025
5-year range
$6.59 / $12.05
FY2021-FY2025
Trend
+66.0%
vs FY2024
Sector context
#23 of 146
Health Care
What the data says
West Pharmaceutical Services's cash per share of $10.94 is higher than 84% of companies in the Health Care sector (FY2025). Cash per Share returned to growth in FY2025 after 2 years of decline, reaching $10.94.
Based on SEC 10-K filings.
10.94 in FY2025 with a 5-year CAGR of +19.2%. Top quartile in the Health Care sector.
Declined from $11.52 to $10.94 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -3.2%
- 5-Year CAGR
- +19.2%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 146This company $10.94 Sector average $27.73
▼
-60.5% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 66.0% year-over-year.
- Ranks #23 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2022.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.94 | +66.0% |
| FY2024 | $6.59 | -42.8% |
| FY2023 | $11.52 | -4.4% |
| FY2022 | $12.05 | +17.0% |
| FY2021 | $10.31 | +126.3% |
| FY2020 | $4.55 | -23.2% |
| FY2019 | $5.93 | +29.8% |
| FY2018 | $4.57 | +41.5% |
| FY2017 | $3.23 | -8.6% |
| FY2016 | $3.53 | +9.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026